Stomach acid drugs raise risk of diarrhea

Key points
- Popular anti-heartburn drugs such as proton-pump inhibitors that block stomach acid production heighten the risk of an increasingly common infectious form of diarrhea, researchers said on Monday.
- Taking such drugs as AstraZeneca's Nexium and Losec or their generic versions tripled the risk of diarrhea blamed on the Clostridium difficile bacteria, the study concluded.
- Frequently prescribed anti-heartburn drugs called H2 antagonists that include GlaxoSmithKline's Zantac were found to double the risk of the bacterial diarrhea, the report said.
- The drugs reduce gastric acid, opening the way for the bacteria to multiply in the digestive system.
Popular anti-heartburn drugs such as proton-pump inhibitors that block stomach acid production heighten the risk of an increasingly common infectious form of diarrhea, researchers said on Monday.
Taking such drugs as AstraZeneca's Nexium and Losec or their generic versions tripled the risk of diarrhea blamed on the Clostridium difficile bacteria, the study concluded.
Frequently prescribed anti-heartburn drugs called H2 antagonists that include GlaxoSmithKline's Zantac were found to double the risk of the bacterial diarrhea, the report said.
The drugs reduce gastric acid, opening the way for the bacteria to multiply in the digestive system.
Clostridium is the third-most common type of infectious diarrhea in patients aged 75 and older, study author Sandra Dial of McGill University, Montreal, wrote in this week's issue of the Journal of the American Medical Association.
Exposure to Clostridium difficile bacteria, which causes infection and inflammation of the intestine, previously occurred mostly during hospital stays, but cases have increasingly been contracted in community settings, the study said. The number of community-acquired cases rose to 22 per 100,000 people in 2004 from 1 in 100,000 a decade earlier, it said.
Recent outbreaks in the United States and in the Canadian province of Quebec indicate strains of the bacteria may be increasingly deadly, according to previous research.
While antibiotics formerly blamed for outbreaks of the illness have declined in use, the acid-blocking drugs have become steadily more popular to treat ulcers and conditions such as gastric reflux disease, the report said.
SOURCE: Journal of the American Medical Association
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Digestive Health →
NewsOnce rare stomach illness becoming more widespread
Donna Heller thought she had cancer. But multiple visits to the doctor after a month with debilitating nausea and diarrhea didn't yield any answers. Convinced she was dying, she met with her lawyer to get her will in…
5 August 2013
NewsNew research identifies risks, interventions for children's GI health
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week® (DDW). In one study targeting obesity,…
20 May 2013
NewsNew 10-year risk predictors identified for liver related
Amsterdam, The Netherlands, Friday 26 April 2013: A study presented today at the International Liver CongressTM 2013 – which evaluated the relationship between non-alcoholic fatty liver disease (NAFLD) , early…
27 April 2013